Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,213,888
  • Shares Outstanding, K 1,253,724
  • Annual Sales, $ 22,449 M
  • Annual Income, $ 5,386 M
  • 60-Month Beta 0.55
  • Price/Sales 3.39
  • Price/Cash Flow 8.31
  • Price/Book 4.19
Trade GILD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.83
  • Number of Estimates 11
  • High Estimate 2.20
  • Low Estimate 1.67
  • Prior Year 1.65
  • Growth Rate Est. (year over year) +10.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.65 +1.91%
on 10/22/20
64.99 -6.46%
on 10/13/20
-2.30 (-3.65%)
since 09/23/20
3-Month
59.65 +1.91%
on 10/22/20
75.65 -19.64%
on 07/24/20
-14.77 (-19.55%)
since 07/23/20
52-Week
59.65 +1.91%
on 10/22/20
85.97 -29.29%
on 03/19/20
-5.79 (-8.70%)
since 10/23/19

Most Recent Stories

More News
Intel, American Express fall; Mattel, Boston Beer rise

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:

UBER : 36.75 (+0.14%)
INTC : 48.20 (-10.58%)
LYFT : 26.02 (+1.72%)
AXP : 100.98 (-3.64%)
MAT : 14.15 (+9.56%)
COF : 77.99 (+1.62%)
GILD : 60.79 (+0.20%)
Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day

Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day

MAT : 14.15 (+9.56%)
INTC : 48.20 (-10.58%)
GILD : 60.79 (+0.20%)
CSL : 131.71 (+1.82%)
WERN : 41.12 (-1.46%)
SmarTrend Watching for Potential Pullback in Shares of Gilead Sciences After 1.22% Gain

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $61.38 to a high of $63.63. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

GILD : 60.79 (+0.20%)
Gilead Sciences Rises 1.22% on Heavy Volume: Watch For Potential Pullback

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $61.38 to a high of $63.63. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

GILD : 60.79 (+0.20%)
TSX Flat at Open

Equities in Canada’s largest market opened slightly lower on Friday, despite strength in energy stocks, ...

GILD : 60.79 (+0.20%)
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

JNJ : 145.24 (+0.11%)
PFE : 38.18 (+2.00%)
GILD : 60.79 (+0.20%)
MRK : 79.83 (+0.78%)
LLY : 142.38 (+0.52%)
BMY : 60.13 (-1.04%)
AMGN : 227.16 (-0.36%)
ABBV : 84.34 (+0.04%)
XLV : 107.82 (+0.37%)
VHT : 209.85 (+0.46%)
IYH : 232.62 (+0.37%)
FHLC : 54.18 (+0.50%)
Gilead Sciences Completes Acquisition of Immunomedics, Inc.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate.

GILD : 60.79 (+0.20%)
IMMU : 87.86 (+0.05%)
Thinking about buying stock in Gilead Sciences, Cassava Sciences, BEST Inc, 3D Systems, or Mattel?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GILD, SAVA, BEST, DDD, and MAT.

DDD : 7.66 (-6.93%)
GILD : 60.79 (+0.20%)
MAT : 14.15 (+9.56%)
Ligand's Captisol Technology Plays Key Role in the Manufacture of Gilead's Veklury, the First FDA-Approved COVID-19 Treatment

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today highlighted the company's role in the manufacturing of Veklury(R) (remdesivir), Gilead Sciences' antiviral drug for the treatment of patients with...

GILD : 60.79 (+0.20%)
LGND : 85.02 (+0.33%)
Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings?

Investors will focus on the HIV franchise's performance and the uptake of Yescarta along with updates on experimental coronavirus treatment, when Gilead (GILD) reports third-quarter 2020 results.

GILD : 60.79 (+0.20%)
IMMU : 87.86 (+0.05%)
VRTX : 211.58 (+0.71%)
HZNP : 77.44 (+1.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 64.61
1st Resistance Point 62.70
Last Price 60.79
1st Support Level 59.82
2nd Support Level 58.85

See More

52-Week High 85.97
Fibonacci 61.8% 75.92
Fibonacci 50% 72.81
Fibonacci 38.2% 69.70
Last Price 60.79
52-Week Low 59.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar